AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock

NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗

$12,48

Prezzo · Mag 22, 2026

Fondamentali al Mag 7, 2026

Margine di Profitto Netto

2.4%

AMRX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$12.47

Capitalizzazione di Mercato

—

P/E (TTM)

57.3

EPS (TTM)

$0.22

Ricavi (TTM)

$3.02B

Rendimento div.

—

ROE

-80.0%

D/E Debito/Patrimonio

-36.3

Intervallo 52 sett.

$7 – $15

AMRX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $3.02B

2016-12-31 → 2025-12-31

EPS $0.22

2018-12-31 → 2025-12-31

Flusso di cassa libero $270M

2018-12-31 → 2025-12-31

Margini 2.4%

2018-12-31 → 2025-12-31

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

AMRX

Mediana dei peer

P/E (TTM)

57.3

42.1

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

AMRX

Mediana dei peer

Gross Margin (Margine lordo)

36.9%

86.3%

Operating Margin (Margine Operativo)

13.1%

—

Net Profit Margin (Margine di Profitto Netto)

2.4%

-3.7%

ROA

2.0%

-13.2%

ROE

-80.0%

-21.9%

ROIC

14.5%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

AMRX

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

-36.3

13657.6

Current Ratio (Rapporto corrente)

2.2

4.1

Quick Ratio

0.3

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

AMRX

Mediana dei peer

Revenue YoY (Ricavi YoY)

8.1%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

10.9%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

8.7%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

AMRX

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$0.22

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

AMRX

Mediana dei peer

AMRX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 11 analisti

Acquisto forte 2 18,2%
Compra 8 72,7%
Mantieni 1 9,1%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

5 analisti · 2026-05-16

Mediana $17.00

← Sotto tutti i target $12.47

Basso $15.00

Alto $19.00

Target mediano $17.00 +36,3%

Target medio $17.00 +36,3%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.06%

Periodo	EPS Actual	EPS Stimato	Sorpresa
31 Marzo 2026	$0.27	$0.17	0.10%
31 Dicembre 2025	$0.21	$0.19	0.02%
30 Settembre 2025	$0.17	$0.14	0.03%
30 Giugno 2025	$0.25	$0.18	0.07%
31 Marzo 2025	$0.21	$0.15	0.06%

Confronto tra pari Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
AMRX	—	57.3	8.1%	2.4%	-80.0%	36.9%
ALMS	—	-3.4	—	-1011.8%	-61.9%	—
GPCR	$14.78B	-86.9	—	—	-12.3%	—
TARS	$3.48B	-51.5	146.7%	-14.7%	-19.7%	—
ELVN	$915M	-8.4	—	—	-21.9%	—
DFTX	$1.32B	-6.5	212.0%	—	-71.0%	—
NKTR	$862M	-4.3	-43.9%	-297.1%	-500.1%	—
PBH	$3.33B	15.2	-4.3%	17.5%	10.2%	54.7%
TRVI	$1.61B	-39.1	—	—	-22.4%	—
ANIP	$1.78B	23.8	43.8%	8.9%	16.6%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15

Dati annuali Conto Economico per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$3.02B	$2.79B	$2.39B	$2.21B	$2.09B	$1.99B	$1.63B	$1.66B	$1.03B
Cost of Revenue	$1.91B	$1.77B	$1.57B	$1.43B	$1.32B	$1.33B	$1.15B	$939M	$507M
Gross Profit	$1.11B	$1.02B	$821M	$785M	$769M	$628M	$353M	$716M	$526M
R&D Expense	$186M	$191M	$164M	$196M	$202M	$180M	$188M	$194M	$171M
SG&A Expense	$527M	$476M	$430M	$400M	$366M	$327M	$290M	$228M	$109M
Operating Income	$394M	$249M	$204M	$-95M	$153M	$91M	$-249M	$-20M	$245M
Other Non-op	$17M	$12M	$8M	$18M	$15M	$3M	$1M	$1M	$-47.0K
Pretax Income	$139M	$-55M	$-40M	$-248M	$31M	$-36M	$-220M	$-203M	$171M
Income Tax	$11M	$19M	$8M	$7M	$11M	$-104M	$383M	$-1M	$2M
Net Income	$72M	$-117M	$-84M	$-255M	$13M	$68M	$-604M	$-20M	$0
EPS (Basic)	$0.23	$-0.38	$-0.48	$-0.86	$0.07	$0.62	$-2.74	$-0.16	·
EPS (Diluted)	$0.22	$-0.38	$-0.48	$-0.86	$0.07	$0.61	$-2.74	$-0.16	·
Shares (Basic)	313,367,000	308,978,000	176,136,000	150,944,000	148,922,000	147,443,000	132,106,000	127,252,000	·
Shares (Diluted)	324,805,000	308,978,000	176,136,000	150,944,000	151,821,000	148,913,000	132,106,000	127,252,000	·
EBITDA	$394M	$249M	$204M	$-95M	$153M	$91M	$-249M	$-20M	·

Stato Patrimoniale 27

Dati annuali Stato Patrimoniale per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$282M	$111M	$92M	$26M	$248M	$341M	$151M	$213M	$74M
Receivables	·	·	·	$742M	$663M	$639M	$604M	$481M	$351M
Inventory	$606M	$612M	$581M	$531M	$489M	$491M	$381M	$457M	$284M
Prepaid Expense	$98M	$81M	$83M	$104M	$110M	$73M	$70M	$128M	$42M
Current Assets	$1.91B	$1.59B	$1.38B	$1.41B	$1.52B	$1.55B	$1.21B	$1.29B	$772M
PP&E (Net)	$443M	$425M	$448M	$470M	$514M	$478M	$478M	$544M	$487M
PP&E (Gross)	$1.05B	$988M	$956M	$916M	$909M	$810M	$754M	$754M	$643M
Accum. Depreciation	$606M	$564M	$508M	$446M	$395M	$332M	$276M	$209M	$156M
Goodwill	$595M	$597M	$599M	$599M	$593M	$523M	$420M	$426M	$26M
Intangibles	$563M	$732M	$890M	$1.10B	$1.17B	$1.30B	$1.38B	$1.65B	$45M
Other Non-current Assets	$58M	$60M	$56M	$103M	$21M	$22M	$44M	$68M	$11M
Total Assets	$3.68B	$3.50B	$3.47B	$3.80B	$3.94B	$4.01B	$3.67B	$4.35B	$1.34B
Accounts Payable	·	$259M	$144M	$166M	$131M	$153M	$103M	$115M	$70M
Current Liabilities	$882M	$1.13B	$847M	$753M	$677M	$677M	$550M	$554M	$297M
Capital Leases	·	·	·	·	·	·	·	$39M	$40M
Deferred Tax	·	·	·	·	·	·	$0	$1M	$2M
Other Non-current Liabilities	·	·	·	$87M	$39M	$83M	$40M	$39M	$8M
Total Liabilities	·	·	·	·	·	·	·	·	$0
Long-term Debt	$2.57B	$2.39B	$2.42B	$2.62B	$2.71B	$2.78B	$2.63B	$2.65B	$1.44B
Total Debt	$2.57B	$2.39B	$2.42B	$2.62B	$2.71B	$2.78B	$2.63B	$2.65B	·
Common Stock	·	·	·	·	·	·	·	·	$10
Paid-in Capital	$572M	$560M	$539M	$692M	$658M	$628M	$607M	$530M	$9M
Retained Earnings	$-535M	$-607M	$-490M	$-406M	$-276M	$-287M	$-378M	$-21M	$-383M
AOCI	$-111M	$-66M	$-32M	$10M	$-25M	$-41M	$-68.0K	$-8M	$-14M
Stockholders' Equity	$-71M	$-109M	$20M	$298M	$360M	$303M	$232M	$505M	$0
Liabilities + Equity	$3.68B	$3.50B	$3.47B	$3.80B	$3.94B	$4.01B	$3.67B	$4.35B	$1.34B
Shares Outstanding	·	·	·	·	·	·	·	·	1,000

Flusso di cassa 12

Dati annuali Flusso di cassa per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Stock-based Comp	$32M	$28M	$27M	$32M	$28M	$21M	$22M	$168M	$0
Deferred Tax	$0	$0	$0	$0	$0	$0	$372M	$-9M	$742.0K
Amort. of Intangibles	$166M	$174M	$163M	$172M	$173M	$175M	$144M	$144M	$73M
Restructuring	$4M	$2M	$2M	$1M	$2M	$2M	$34M	$56M	$0
Operating Cash Flow	$340M	$295M	$346M	$65M	$242M	$379M	$2M	$250M	$234M
CapEx	$70M	$52M	$43M	$46M	$48M	$56M	$47M	$83M	$95M
Investing Cash Flow	$-112M	$-63M	$-69M	$-174M	$-194M	$-318M	$-20M	$-396M	$-99M
Dividends Paid	·	·	·	·	·	$0	$0	$183M	$375M
Financing Cash Flow	$-32M	$-212M	$-213M	$-107M	$-138M	$132M	$-46M	$288M	$-95M
Net Change in Cash	$195M	$19M	$64M	$-222M	$-90M	$194M	$-66M	$141M	$40M
Taxes Paid	$21M	$15M	$2M	$13M	$-16M	$100M	$10M	$35M	$-6M
Free Cash Flow	$270M	$243M	$302M	$19M	$194M	$323M	$-45M	$167M	·

Redditività 8

Dati annuali Redditività per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	36.9%	36.5%	34.3%	35.5%	36.7%	31.5%	21.7%	43.1%	·
Operating Margin	13.1%	8.9%	8.5%	-4.3%	7.3%	4.6%	-15.3%	-1.2%	·
Net Margin	2.4%	-2.6%	-3.3%	-12.2%	0.63%	4.6%	-22.2%	-1.2%	·
Pretax Margin	4.6%	-2.0%	-1.7%	-11.2%	1.5%	-1.8%	-13.5%	-12.2%	·
EBITDA Margin	13.1%	8.9%	8.5%	-4.3%	7.3%	4.6%	-15.3%	-1.2%	·
ROA	2.0%	-2.1%	-2.2%	-7.0%	0.33%	2.4%	-9.0%	-0.69%	·
ROE	-80.0%	165.1%	-49.8%	-82.2%	4.0%	34.0%	-98.2%	-7.8%	·
ROIC	14.5%	14.7%	10.1%	-3.3%	3.2%	-5.7%	-23.8%	-0.62%	·

Liquidità e Solvibilità 4

Dati annuali Liquidità e Solvibilità per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	2.2	1.4	1.6	1.9	2.2	2.3	2.2	2.3	·
Quick Ratio	0.3	0.1	0.1	1.0	1.3	1.4	1.4	1.3	·
Debt / Equity	-36.3	-21.8	122.3	8.8	7.5	9.2	11.3	5.3	·
LT Debt / Equity	-36.2	-19.8	120.6	8.7	7.4	9.0	11.2	5.2	·

Efficienza 3

Dati annuali Efficienza per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.8	0.8	0.7	0.6	0.5	0.5	0.4	0.6	·
Inventory Turnover	3.1	3.0	2.8	2.8	2.7	3.1	2.7	2.6	·
Receivables Turnover	·	·	·	3.2	3.2	3.2	3.0	4.0	·

Per Azione 3

Dati annuali Per Azione per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue / Share	$9.29	$9.04	$13.59	$14.66	$13.79	$13.38	·	·	·
Cash Flow / Share	$1.05	$0.96	$1.96	$0.43	$1.59	$2.55	·	·	·
EPS (TTM)	$0.22	$-0.38	$-0.48	$-0.86	$0.07	$0.61	$-2.74	$-0.16	·

Tassi di Crescita 7

Dati annuali Tassi di Crescita per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	8.1%	16.7%	8.2%	5.7%	5.1%	·	·	·	·
Revenue CAGR 3Y	10.9%	10.1%	6.3%	·	·	·	·	·	·
Revenue CAGR 5Y	8.7%	·	·	·	·	·	·	·	·
EPS YoY	·	·	·	·	-88.5%	·	·	·	·
EPS CAGR 5Y	-18.4%	·	·	·	·	·	·	·	·
Net Income YoY	·	·	·	·	-80.6%	·	·	·	·
Net Income CAGR 5Y	1.2%	·	·	·	·	·	·	·	·

Valutazione (TTM) 6

Dati annuali Valutazione (TTM) per AMRX
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$3.02B	$2.79B	$2.39B	$2.21B	$2.09B	$1.99B	$1.63B	$1.66B	·
Net Income TTM	$72M	$-117M	$-84M	$-255M	$13M	$68M	$-604M	$-20M	·
P/E	57.3	-20.8	-12.6	-2.3	68.4	7.5	-1.8	-84.6	·
Earnings Yield	1.8%	-4.8%	-7.9%	-43.2%	1.5%	13.4%	-56.9%	-1.2%	·
Payout Ratio	·	·	·	·	·	0.00%	0.00%	-926.8%	·
Annual Payout	·	·	·	·	·	$0	$0	$183M	·

Conto Economico 15

Dati trimestrali Conto Economico per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$723M	$814M	$785M	$725M	$695M	$731M	$702M	$702M	$659M	$617M	$620M	$599M	$558M	$610M	$546M	$559M
Cost of Revenue	$402M	$517M	$511M	$438M	$440M	$468M	$433M	$452M	$421M	$427M	$388M	$379M	$379M	$394M	$351M	$359M
Gross Profit	$320M	$297M	$274M	$286M	$256M	$263M	$270M	$250M	$238M	$190M	$233M	$220M	$178M	$215M	$194M	$201M
R&D Expense	$38M	$35M	$63M	$48M	$40M	$54M	$61M	$36M	$39M	$46M	$41M	$38M	$39M	$42M	$50M	$51M
SG&A Expense	$139M	$146M	$138M	$124M	$118M	$129M	$119M	$116M	$113M	$109M	$113M	$106M	$102M	$102M	$100M	$99M
Operating Income	$142M	$112M	$70M	$111M	$100M	$76M	$89M	$95M	$-11M	$14M	$76M	$80M	$34M	$36M	$44M	$-199M
Other Non-op	$742.0K	$13M	$1M	$2M	$518.0K	$2M	$1M	$4M	$4M	$2M	$2M	$417.0K	$4M	$4M	$6M	$7M
Pretax Income	$80M	$55M	$-5M	$52M	$37M	$-15M	$15M	$20M	$-76M	$-83M	$23M	$30M	$-9M	$-8M	$2M	$-233M
Income Tax	$2M	$6M	$-23M	$16M	$13M	$5M	$4M	$4M	$6M	$10M	$-2M	$-23.0K	$668.0K	$-2M	$5M	$7M
Net Income	$62M	$35M	$2M	$22M	$12M	$-31M	$-156.0K	$6M	$-92M	$-99M	$10M	$12M	$-7M	$4M	$-8M	$-242M
EPS (Basic)	$0.20	$0.11	$0.01	$0.07	$0.04	$-0.10	$0.00	$0.02	$-0.30	$-0.57	$0.06	$0.08	$-0.05	$-0.03	$-0.02	$-0.80
EPS (Diluted)	$0.19	$0.10	$0.01	$0.07	$0.04	$-0.10	$0.00	$0.02	$-0.30	$-0.57	$0.06	$0.08	$-0.05	$-0.03	$-0.02	$-0.80
Shares (Basic)	316,023,000	-625,594,000	314,168,000	313,739,000	311,054,000	-617,065,000	309,647,000	309,117,000	307,279,000	-283,930,000	154,219,000	153,738,000	152,109,000	-301,334,000	151,393,000	150,993,000
Shares (Diluted)	328,933,000	-646,273,000	324,754,000	322,363,000	323,961,000	-626,905,000	309,647,000	318,957,000	307,279,000	-290,551,000	159,691,000	154,887,000	152,109,000	-301,334,000	151,393,000	150,993,000
EBITDA	$142M	·	$70M	$111M	$100M	·	$89M	$95M	$-11M	·	$76M	$80M	$34M	·	$44M	$-199M

Stato Patrimoniale 22

Dati trimestrali Stato Patrimoniale per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$198M	$282M	$201M	$72M	$59M	$111M	$74M	$44M	$47M	$92M	$87M	$109M	$145M	$26M	$87M	$92M
Receivables	·	·	·	·	·	·	·	·	·	·	·	·	$546M	·	$629M	$689M
Inventory	$642M	$606M	$614M	$609M	$601M	$612M	$596M	$576M	$571M	·	$576M	$551M	$529M	·	$544M	$533M
Prepaid Expense	$103M	$98M	$102M	$85M	$89M	$81M	$82M	$82M	$87M	·	$91M	$82M	$81M	·	$150M	$232M
Current Assets	$1.80B	$1.91B	$1.84B	$1.58B	$1.51B	$1.59B	$1.51B	$1.49B	$1.38B	·	$1.46B	$1.42B	$1.31B	·	$1.42B	$1.55B
PP&E (Net)	$445M	$443M	$435M	$440M	$427M	$425M	$431M	$425M	$440M	·	$452M	$459M	$463M	·	$470M	$484M
PP&E (Gross)	·	$1.05B	·	·	·	$988M	·	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	$606M	·	·	·	$564M	·	·	·	·	·	·	·	·	·	·
Goodwill	$594M	$595M	$596M	$597M	$597M	$597M	$598M	$599M	$599M	$599M	$599M	$599M	$599M	$599M	$600M	$601M
Intangibles	$535M	$563M	$588M	$650M	$689M	$732M	$780M	$820M	$859M	·	$983M	$1.02B	$1.06B	·	$1.16B	$1.20B
Other Non-current Assets	$55M	$58M	$39M	$45M	$45M	$60M	$36M	$77M	$74M	·	$89M	$93M	$86M	·	$108M	$80M
Total Assets	$3.54B	$3.68B	$3.60B	$3.42B	$3.37B	$3.50B	$3.46B	$3.51B	$3.46B	·	$3.69B	$3.70B	$3.63B	·	$3.87B	$4.04B
Accounts Payable	·	·	$266M	$206M	$193M	·	$235M	$200M	$175M	·	$177M	$140M	$137M	·	$531M	$562M
Current Liabilities	$728M	$882M	$862M	$1.11B	$1.08B	$1.13B	$1.10B	$1.11B	$834M	·	$761M	$777M	$704M	·	$818M	$993M
Other Non-current Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	$41M	·	$78M	$79M
Long-term Debt	$2.57B	$2.57B	$2.57B	$2.18B	$2.19B	$2.39B	$2.39B	$2.40B	$2.41B	·	$2.57B	$2.58B	$2.59B	·	$2.64B	$2.65B
Total Debt	$2.57B	·	$2.57B	$2.18B	$2.19B	·	$2.39B	$2.40B	$2.41B	·	$2.57B	$2.58B	$2.59B	·	$2.64B	$2.65B
Paid-in Capital	$536M	$572M	$563M	$555M	$546M	$560M	$553M	$546M	$539M	·	$715M	$708M	$701M	·	$684M	$676M
Retained Earnings	$-473M	$-535M	$-570M	$-572M	$-595M	$-607M	$-576M	$-576M	$-582M	·	$-392M	$-401M	$-413M	·	$-402M	$-399M
AOCI	$-112M	$-111M	$-106M	$-97M	$-86M	$-66M	$-74M	$-30M	$-24M	·	$4M	$8M	$4M	·	$13M	$868.0K
Stockholders' Equity	$-45M	$-71M	$-109M	$-112M	$-132M	$-109M	$-93M	$-57M	$-64M	·	$331M	$318M	$294M	·	$297M	$280M
Liabilities + Equity	$3.54B	$3.68B	$3.60B	$3.42B	$3.37B	$3.50B	$3.46B	$3.51B	$3.46B	·	$3.69B	$3.70B	$3.63B	·	$3.87B	$4.04B

Flusso di cassa 10

Dati trimestrali Flusso di cassa per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Stock-based Comp	$9M	$8M	$8M	$8M	$7M	$7M	$7M	$7M	$7M	$6M	$7M	$7M	$8M	$8M	$8M	$8M
Amort. of Intangibles	$30M	$36M	$40M	$46M	$45M	$50M	$43M	$40M	$40M	$41M	$41M	$41M	$41M	$45M	$44M	$42M
Restructuring	$650.0K	$2M	$143.0K	$1M	$571.0K	$493.0K	$172.0K	$220.0K	$1M	$114.0K	$1M	$82.0K	$510.0K	$109.0K	$581.0K	$0
Operating Cash Flow	$-27M	$130M	$118M	$84M	$7M	$118M	$142M	$40M	$-4M	$136M	$81M	$-11M	$140M	$-23M	$94M	$-126M
CapEx	$8M	$22M	$12M	$23M	$13M	$15M	$17M	$11M	$9M	$10M	$12M	$12M	$10M	$11M	$19M	$5M
Investing Cash Flow	$-22M	$-45M	$-22M	$-27M	$-18M	$-16M	$-21M	$-6M	$-20M	$-32M	$-13M	$-12M	$-12M	$-11M	$-49M	$-16M
Financing Cash Flow	$-59M	$-10M	$59M	$-42M	$-39M	$-61M	$-92M	$-35M	$-23M	$-101M	$-87M	$-12M	$-13M	$-22M	$-46M	$23M
Net Change in Cash	$-109M	$75M	$155M	$15M	$-50M	$40M	$29M	$-2M	$-47M	$4M	$-19M	$-36M	$116M	$-61M	$-2M	$-118M
Taxes Paid	$2M	$4M	$5M	$9M	$-4M	$6M	$-1M	$15M	$5M	$2M	$-3M	$496.0K	$3M	$23M	$-3M	$-11M
Free Cash Flow	$-35M	·	·	·	$-6M	·	·	·	$-14M	·	·	·	$130M	·	·	·

Redditività 8

Dati trimestrali Redditività per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Gross Margin	44.3%	·	34.9%	39.5%	36.8%	·	38.4%	35.6%	36.1%	·	37.5%	36.7%	32.0%	·	35.6%	35.9%
Operating Margin	19.6%	·	9.0%	15.4%	14.4%	·	12.6%	13.6%	-1.6%	·	12.2%	13.4%	6.2%	·	8.1%	-35.5%
Net Margin	8.6%	·	0.30%	3.1%	1.8%	·	-0.02%	0.85%	-13.9%	·	2.5%	3.7%	-2.8%	·	-1.4%	-43.3%
Pretax Margin	11.1%	·	-0.67%	7.1%	5.4%	·	2.2%	2.9%	-11.5%	·	3.7%	5.0%	-1.7%	·	0.40%	-41.6%
EBITDA Margin	19.6%	·	9.0%	15.4%	14.4%	·	12.6%	13.6%	-1.6%	·	12.2%	13.4%	6.2%	·	8.1%	-35.5%
ROA	1.8%	·	0.07%	0.65%	0.36%	·	0.00%	0.17%	-2.6%	·	0.41%	0.57%	-0.42%	·	-0.19%	-6.0%
ROE	-70.3%	·	-2.3%	-26.4%	-12.5%	·	-0.13%	4.6%	-79.5%	·	5.0%	7.4%	-4.6%	·	-2.4%	-77.3%
ROIC	5.5%	·	-9.9%	3.7%	3.2%	·	2.9%	3.4%	-0.50%	·	2.8%	2.8%	1.3%	·	-1.7%	-7.0%

Liquidità e Solvibilità 4

Dati trimestrali Liquidità e Solvibilità per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	2.5	·	2.1	1.4	1.4	·	1.4	1.3	1.7	·	1.9	1.8	1.9	·	1.7	1.6
Quick Ratio	0.3	·	0.2	0.1	0.1	·	0.1	0.0	0.1	·	0.1	0.1	1.0	·	0.9	0.8
Debt / Equity	-56.6	·	-23.5	-19.4	-16.6	·	-25.6	-41.8	-37.8	·	7.8	8.1	8.8	·	8.9	9.5
LT Debt / Equity	-56.5	·	-23.4	-19.1	-16.4	·	-23.2	-37.9	-37.3	·	7.7	8.0	8.7	·	8.8	9.4

Efficienza 3

Dati trimestrali Efficienza per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.2	·	0.2	0.2	0.1	·	0.1	0.1
Inventory Turnover	0.6	·	0.8	0.7	0.8	·	0.7	0.8	0.8	·	0.7	0.7	0.7	·	0.7	0.7
Receivables Turnover	·	·	·	·	·	·	·	·	·	·	·	·	1.0	·	0.9	0.8

Per Azione 3

Dati trimestrali Per Azione per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue / Share	$2.20	·	$2.42	$2.25	$2.15	·	$2.27	$2.20	$2.15	·	$3.88	$3.87	$3.67	·	$3.60	$3.70
Cash Flow / Share	$-0.08	·	·	·	$0.02	·	·	·	$-0.01	·	·	·	$0.92	·	·	·
EPS (TTM)	$0.31	·	$0.12	$0.13	$-0.24	·	$-0.22	$-0.14	$-0.21	·	$0.07	$-0.79	$-0.88	·	$-0.86	$-0.74

Valutazione (TTM) 4

Dati trimestrali Valutazione (TTM) per AMRX
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$2.93B	·	$2.91B	$2.82B	$2.76B	·	$2.68B	$2.58B	$2.44B	·	$2.32B	$2.26B	$2.16B	·	$2.13B	$2.12B
Net Income TTM	$99M	·	$37M	$40M	$-74M	·	$-76M	$-64M	$-77M	·	$7M	$-245M	$-266M	·	$-266M	$-229M
P/E	40.1	·	83.4	62.2	-34.9	·	-37.8	-45.4	-28.9	·	60.3	-3.9	-1.6	·	-2.3	-4.3
Earnings Yield	2.5%	·	1.2%	1.6%	-2.9%	·	-2.6%	-2.2%	-3.5%	·	1.7%	-25.5%	-63.3%	·	-42.6%	-23.3%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$3.02B	$2.79B	$2.39B	$2.21B	$2.09B
Margine Lordo %	36.9%	36.5%	34.3%	35.5%	36.7%
Margine Operativo %	13.1%	8.9%	8.5%	-4.3%	7.3%
Utile netto	$72M	$-117M	$-84M	$-255M	$13M
EPS Diluito	$0.22	$-0.38	$-0.48	$-0.86	$0.07

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	-36.3	-21.8	122.3	8.8	7.5
Rapporto corrente	2.2	1.4	1.6	1.9	2.2
Quick Ratio	0.3	0.1	0.1	1.0	1.3

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$270M	$243M	$302M	$19M	$194M

Ultime notizie Notizie recenti che menzionano questa società

Farmaci Generici Focalizzati Amneal Pharmaceuticals Ricavi Superano 800 Milioni di Dollari - Amneal Pharmaceuticals ( NASDAQ : AMRX ) www.benzinga.com · 2 mesi, 3 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

AMRX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

AMRX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

AMRX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto tra pari Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi